作者: M. D. Berger , B. Gerber , K. Arn , O. Senn , U. Schanz
DOI: 10.3324/HAEMATOL.2011.047035
关键词: Hematopoietic stem cell transplantation 、 Hematology 、 Internal medicine 、 Hemoglobin 、 Blood cell 、 Transplantation 、 Medicine 、 Chemotherapy 、 Red blood cell 、 Anemia 、 Surgery
摘要: Background Traditionally, single-unit red blood cell transfusions were believed to be insufficient treat anemia, but recent data suggest that they may lead a safe reduction of transfusion requirements. We tested this hypothesis by changing from double- policy.Design and Methods performed retrospective cohort study in patients with hematologic malignancies receiving intensive chemotherapy or hematopoietic stem transplantation. The major end-points the total number units per therapy cycle day aplasia. comprised 139 who received 272 cycles. Overall 2212 administered 1548 transfusions.Results During periods policies, one unit was transfused 25% 84% cases median two one, respectively. Single-unit led usage 24% aplasia day, not associated higher out-patient frequency. In multivariate analysis, resulted 2.7 treatment (P=0.001). pre-transfusion hemoglobin levels lower during period (median 61 g/L versus 64 g/L) more values 60 gl/L less (47% 26%). There no evidence severe bleeding platelet overall survival similar both cohorts.Conclusions Implementing policy saves and, thereby, reduces risks allogeneic transfusions.